Provided by Tiger Trade Technology Pte. Ltd.

Tempest Therapeutics Inc.

1.74
-0.0100-0.57%
Post-market: 2.030.2900+16.67%19:59 EDT
Volume:654.03K
Turnover:1.12M
Market Cap:23.46M
PE:-0.17
High:1.79
Open:1.76
Low:1.65
Close:1.75
52wk High:12.23
52wk Low:1.65
Shares:13.48M
Float Shares:8.64M
Volume Ratio:3.60
T/O Rate:7.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.1030
EPS(LYR):-19.4955
ROE:-405.03%
ROA:-89.32%
PB:3.70
PE(LYR):-0.09

Loading ...

Tempest Therapeutics Inc - Plans to Progress Additional Dual Targeting Tpst-3003 CAR-T Program

THOMSON REUTERS
·
Feb 11

Tempest Therapeutics Inc - Expects Phase 2B Initiation for Tpst-2003 by 2026 in China

THOMSON REUTERS
·
Feb 11

Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets

THOMSON REUTERS
·
Feb 11

Tempest Therapeutics Inc. Files Initial Statement of Beneficial Ownership for CEO and President Matthew Angel

Reuters
·
Feb 07

Tempest Therapeutics kündigt Privatplatzierung und unregistrierten Aktienverkauf an

Reuters
·
Feb 07

BRIEF-Tempest Announces Closing Of Strategic Acquisition Of Dual-Targeting Car-T Assets

Reuters
·
Feb 05

Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets

THOMSON REUTERS
·
Feb 05

Tempest Therapeutics Faces Nasdaq Delisting Notice Over Missed Annual Meeting Deadline

Reuters
·
Jan 10

Tempest Therapeutics Inc. Announces Date for Upcoming Annual Stockholder Meeting

Reuters
·
Dec 03, 2025

BRIEF-Tempest Announces Closing Of Up To $8.35 Million Registered Direct Offering Of Common Stock And Concurrent Private Placement Of Warrants Priced At-The-Market Under Nasdaq Rules

Reuters
·
Nov 27, 2025

Tempest Therapeutics Raises $8.35 Million Through Registered Direct Offering and Private Placement

Reuters
·
Nov 27, 2025

Top Midday Decliners

MT Newswires Live
·
Nov 26, 2025

Tempest Therapeutics Announces Private Placement of Unregistered Warrants for Up to $4.1 Million

Reuters
·
Nov 25, 2025

Tempest Announces up to $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Nov 25, 2025

Tempest Therapeutics Inc - Entered Definitive Agreement for Purchase & Sale of 1.2 Mln Common Shares at $3.625 per Share

THOMSON REUTERS
·
Nov 25, 2025

Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results

Benzinga
·
Nov 20, 2025

Tempest Therapeutics Q3 EPS USD -0.79

Reuters
·
Nov 20, 2025

Why Tempest Therapeutics (TPST) Stock Is Down 45% Today

Benzinga
·
Nov 20, 2025

Tempest Therapeutics Announces Private Placement of Unregistered Shares

Reuters
·
Nov 19, 2025

Tempest Therapeutics Inc - Matt Angel to Become President and CEO

THOMSON REUTERS
·
Nov 19, 2025